COMMUNIQUÉS West-GlobeNewswire

Une thérapie révolutionnaire pour l’insuffisance cardiaque avancée : Repairon renforce son équipe de direction avec la nomination de Detlef Schumann, Ph.D., au poste de directeur des opérations
19/10/2026
Ce dirigeant du secteur biotechnologique apporte une expérience internationale en matière de direction et d’opérations, visant à accélérer le développement clinique, à étendre les activités et à mettre en œuvre des [...]
Groundbreaking therapy for advanced heart failure: Repairon Strengthens Executive Leadership with Appointment of Detlef Schumann, Ph.D. as Chief Operating Officer
19/10/2026
Biotech executive brings global leadership and operations experience to speed clinical development, expand operations, and carry out strategic growth plans. GÖTTINGEN, Germany and PROVIDENCE, R.I., Oct. 19, 2026 (GLOBE [...]
VIRBAC: Solid growth of +7.9% at CERS in YTD September 2026, fueled by double-digit growth of our Supercharge platforms
19/10/2026
End of September 2026 revenue reached €1,168 million : +7.9% at constant exchange rate and scope (at CERS) vs YTD September 2025 +5.9% at actual rates impacted by currency headwinds Balanced growth in both segments: [...]
VIRBAC: Solide croissance de +7,9 % à TCC à fin septembre 2026, portée par la croissance à deux chiffres de nos plateformes Supercharge
19/10/2026
Le chiffre d'affaires à fin septembre 2026 atteint 1 168 millions d'euros : +7,9 % à taux de change et périmètre constants (PCC) par rapport à fin septembre 2025 +5,9 % à taux réels, impacté par des effets de change [...]
Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors
19/10/2026
New collaboration expands access to multilingual, community-based care across seven Northern and Southern California counties ORANGE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning [...]
Strata Earns HFMA Peer Review Designation for 13 Consecutive Years
19/10/2026
Recognition reflects Strata’s commitment to delivering customer value and advancing healthcare financial decision-making CHICAGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Strata Decision Technology today announced that after [...]
Baylor Genetics to Highlight Clinical and Diagnostic Utility of Genome Sequencing at the 2026 American Society of Human Genetics Annual Meeting
19/10/2026
HOUSTON, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will share new [...]
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
19/10/2026
ROCKVILLE, Md., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Indivior to Report Third Quarter 2026 Financial Results
19/10/2026
RICHMOND, Va., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its third quarter 2026 financial results on Thursday, October 29, 2026. The results will [...]
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
19/10/2026
CAMBRIDGE, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area
19/10/2026
Company is Organizing an Independent Texas-based Manufacturing Platform, Contributing Proprietary Composite Technology and Engineering Expertise to Support Planned U.S. Drone-Frame Production Strategic Real Estate [...]
Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
19/10/2026
- FDA approves IDE supplement expanding REGAIN from 10 to 20 patients, with additional study endpoints and interim analysis - - Abstract authored by REGAIN study principal investigator Dr. Joshua Palmer of The Ohio [...]
Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.
19/10/2026
- Largest Shareholder Increases Position as Dogwood Advances Halneuron ® Toward Topline Phase 2b Data Readout in November 2026 - - Expected Proceeds from the Investment Enable Acceleration of Phase 3 Preparatory [...]
Decamen App Launches Personalized Military-Style Home Workout Plan for Busy Men
19/10/2026
New App Turns a Short Quiz Into a Personalized Training Plan, Meal Plan, and Coach Chat NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Decamen has launched a performance and wellness app for men built around military-style [...]
Johnson & Johnson announces new TREMFYA® (guselkumab) data showing durable 3-year outcomes in moderate to severe Crohn’s disease and expanding evidence in perianal fistula
19/10/2026
New TREMFYA ® (guselkumab) 3-year as-observed data show clinical remission rates of up to 94% (172/183 patients) and endoscopic remission rates of up to 52% (89/172 patients) in adults with moderate to severe Crohn’s [...]
Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
19/10/2026
Non-clinical R&D activities to be wound down; resources to be focused on executing the Phase 2b trial Workforce reduced by approximately 60%; management and CEO salaries reduced Plan designed to substantially reduce [...]
Enable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery System
19/10/2026
Sanofi's CirCLIQ® Injector, developed using enFuse technology, has been approved to administer Sarclisa subcutaneous formulation, in combination with approved standard-of-care regimens, for patients with multiple [...]
ArriVent Announces Cancer Cell Publication Highlighting Firmonertinib in EGFR PACC-Mutant Non-Small Cell Lung Cancer
19/10/2026
NEWTOWN SQUARE, Pa., Oct. 19, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative [...]
argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026
19/10/2026
Results from the global Phase 3 ALKIVIA study, the first registrational study investigating an FcRn blocker in autoimmune myositis, show efgartigimod provides clinically meaningful improvements in IMNM and DM Patient [...]

Pages